Sarah Sinnett, Ph.D.

 Featured Publications

Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Sinnett SE, Boyle E, Lyons C, Gray SJ, Brain 2021 May

Gene Transfer Therapy for Neurodevelopmental Disorders.

Ozlu C, Bailey RM, Sinnett S, Goodspeed KD, Dev Neurosci 2021 Apr 1-11

Intellectual and Developmental Disabilities Research Centers: A Multidisciplinary Approach to Understand the Pathogenesis of Methyl-CpG Binding Protein 2-related Disorders.

Fagiolini M, Patrizi A, LeBlanc J, Jin LW, Maezawa I, Sinnett S, Gray SJ, Molholm S, Foxe JJ, Johnston MV, Naidu S, Blue M, Hossain A, Kadam S, Zhao X, Chang Q, Zhou Z, Zoghbi H, Neuroscience 2020 10 445 190-206

AAV-Mediated Gene Therapy in CNS Genetic Disorders

Casy W, Ling Q, Shaffo FC, Sinnett SE, Gray SJ. Rosenberg?s Molecular and Genetic Basis of Neurological and Psychiatric Disease 2020 Sixth Edition

Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.

Sinnett SE, Gray SJ Discov Med 2017 Oct 24 132 153-159

Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome.

Gadalla KKE, Vudhironarit T, Hector RD, Sinnett S, Bahey NG, Bailey MES, Gray SJ, Cobb SR Mol Ther Methods Clin Dev 2017 Jun 5 180-190

Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery.

Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ Mol Ther Methods Clin Dev 2017 Jun 5 106-115

The Role of AMPK in Drosophila melanogaster.

Sinnett SE, Brenman JE, Exp Suppl 2016 107 389-401

Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators.

Sinnett SE, Brenman JE, Pharmacol. Ther. 2014 Jul 143 1 111-8

A High Throughput Assay for Discovery of Small Molecules that Bind AMP-activated Protein Kinase (AMPK).

Sinnett SE, Sexton JZ, Brenman JE, Curr Chem Genom Transl Med 2013 7 30-8